Calithera biosciences, inc. (CALA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13
Revenue:
Total revenue

-

-

-

-

-

0

0

17,065

5,189

-

7,254

7,255

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

4,192

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

4,192

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

20,125

17,902

17,221

20,928

20,239

16,977

16,420

17,305

15,493

15,496

10,833

10,142

6,640

6,593

6,313

7,776

7,066

5,833

6,752

5,533

5,630

4,972

3,894

4,183

3,318

2,735

General and administrative

4,946

4,551

3,906

3,984

4,164

3,247

3,087

3,498

3,508

3,300

3,074

2,848

3,308

3,011

2,319

2,665

2,591

2,295

2,198

2,341

2,237

1,866

1,347

1,309

832

583

Total operating expenses

25,071

22,453

21,127

24,912

24,403

20,224

19,507

20,803

19,001

18,796

13,907

12,990

9,948

9,604

8,632

10,441

9,657

8,128

8,950

7,874

7,867

6,838

5,241

5,492

4,150

3,318

Loss from operations

-25,071

-22,453

-21,127

-24,912

-24,403

-20,224

-19,507

-3,738

-13,812

-11,542

-6,653

-5,735

-5,756

-9,604

-8,632

-10,441

-9,657

-8,128

-8,950

-7,874

-7,867

-6,838

-5,241

-5,492

-4,150

-3,318

Interest and other income, net

625

725

834

760

716

-

658

663

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income, net

-

-

-

-

-

-

-

-

606

-

582

541

169

84

88

83

75

60

50

56

9

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

1

1

-

Net loss

-24,446

-21,728

-20,293

-24,152

-23,687

-19,499

-18,849

-3,075

-13,206

-10,974

-6,071

-5,194

-5,587

-9,520

-8,544

-10,358

-9,582

-8,068

-8,900

-7,818

-7,858

-6,833

-5,239

-5,491

-4,149

-3,318

Net loss per share, basic and diluted

-0.38

-0.33

-0.38

-0.58

-0.61

-0.51

-0.52

-0.09

-0.37

-0.30

-0.17

-0.15

-0.22

-0.44

-0.44

-0.55

-0.52

-0.44

-0.49

-0.44

-0.44

59.20

-16.85

-24.22

-22.80

-34.22

Weighted average common shares used to compute net loss per share, basic and diluted

64,556

55,304

53,775

41,303

38,866

38,358

36,405

35,874

35,779

35,702

35,475

35,348

25,279

21,061

19,507

18,987

18,389

18,166

18,105

17,963

17,946

17,888

311

227

182

97